m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00143)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
FAM225A
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | Caco-2 cell line | Homo sapiens |
Treatment: shMETTL3 Caco-2 cells
Control: shNTC Caco-2 cells
|
GSE167075 | |
Regulation |
|
logFC: 1.41E+00 p-value: 1.18E-04 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Family with sequence similarity 225 member A (FAM225A) functioned as a competing endogenous RNA (ceRNA) for sponging miR-590-3p and miR-1275, leading to the upregulation of their target integrin beta-3 (ITGB3), and the activation of FAK/PI3K/Akt signaling to promote Nasopharyngeal carcinoma cell proliferation and invasion. FAM225A showed lower RNA stability after silencing of METTL3. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Nasopharyngeal carcinoma | ICD-11: 2B6B | ||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | 5-8F | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C528 |
6-10B | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C529 | |
C666-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_7949 | |
CNE-1 | Normal | Homo sapiens | CVCL_6888 | |
CNE-2 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_6889 | |
HK1 | Nasopharyngeal carcinoma | Acipenser baerii | CVCL_YE27 | |
HNE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_0308 | |
HONE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_8706 | |
N2Tert (The human immortalized nasopharyngeal epithelial cell lines) | ||||
NP69 (A human immortalized nasopharyngeal epithelial) | ||||
S18 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0U9 | |
S26 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0UB | |
SUNE1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_6946 | |
In-vivo Model | For the tumor growth model, 1 × 106 HNE1-Scrambled or HNE1-shFAM2225A 2# cells were injected into the axilla of the mice, and the tumor size was measured every 3 days. | |||
Nasopharyngeal carcinoma [ICD-11: 2B6B]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Family with sequence similarity 225 member A (FAM225A) functioned as a competing endogenous RNA (ceRNA) for sponging miR-590-3p and miR-1275, leading to the upregulation of their target integrin beta-3 (ITGB3), and the activation of FAK/PI3K/Akt signaling to promote Nasopharyngeal carcinoma cell proliferation and invasion. FAM225A showed lower RNA stability after silencing of METTL3. | |||
Responsed Disease | Nasopharyngeal carcinoma [ICD-11: 2B6B] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | 5-8F | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C528 |
6-10B | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C529 | |
C666-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_7949 | |
CNE-1 | Normal | Homo sapiens | CVCL_6888 | |
CNE-2 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_6889 | |
HK1 | Nasopharyngeal carcinoma | Acipenser baerii | CVCL_YE27 | |
HNE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_0308 | |
HONE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_8706 | |
N2Tert (The human immortalized nasopharyngeal epithelial cell lines) | ||||
NP69 (A human immortalized nasopharyngeal epithelial) | ||||
S18 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0U9 | |
S26 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0UB | |
SUNE1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_6946 | |
In-vivo Model | For the tumor growth model, 1 × 106 HNE1-Scrambled or HNE1-shFAM2225A 2# cells were injected into the axilla of the mice, and the tumor size was measured every 3 days. | |||